ICARES Medicus, Inc. (TPEX:6612)

Taiwan · Delayed Price · Currency is TWD

73.30

+0.60 (0.83%)

Jun 18, 2026, 12:56 PM CST

-34.45% (1Y)

Market Cap	3.47B -33.2%
Revenue (ttm)	1.13B +13.6%
Net Income	42.22M -66.9%
EPS	0.89 -67.1%
Shares Out	47.34M
PE Ratio	82.49
Forward PE	n/a
Dividend	0.30 (0.41%)
Ex-Dividend Date	Aug 22, 2025

Volume	23,565
Open	72.50
Previous Close	72.70
Day's Range	72.50 - 73.80
52-Week Range	66.00 - 113.18
Beta	0.28
Analysts	Buy
Price Target	64.46 (-12.06%)
Earnings Date	Aug 13, 2026

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, United Kingdom, Japan, Spain, China, Germany, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, farsightedness, presbyopia, or astigmatism, as well as related technical services. In addition, it offers artificial crystal products; and l... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2011

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 6612

Full Company Profile

Financial Performance

In 2025, ICARES Medicus's revenue was 1.13 billion, an increase of 31.54% compared to the previous year's 859.79 million. Earnings were 51.23 million, a decrease of -50.32%.

Financial Statements